Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ULIPRISTAL ACETATE
- Drospirenone-only Pill as Emergency Contraception
- Disparities in Emergency Contraceptive Metabolism Dictate Efficacy
- Ulipristal Acetate for Use in Early Pregnancy Loss
- Use of Ulipristal Acetate in Induction of Second Trimester Missed Abortion
- UA Versus UAE in Treatment of Fibroids
- Ovarian Function With ENG Implant and UPA Use
- Ulipristal Acetate in Symptomatic Uterine Fibroid
- Ulipristal Acetate for Cervical Preparation
- Study Comparing Emergency Contraception Effectiveness in Women Who Weight ≥ 80 kg
- Aromatase Plus GnRH Analogue Versus Ulippristal Acetate in Uterine Fibroids
- On Demand Contraception: Ulipristal Acetate Plus a COX-2 Inhibitor at Peak Fertility
- Mode of Action Study of Vilaprisan and Ulipristal Acetate in Patients With Uterine Fibroids for Whom Surgery is Planned
- Effect of Ulipristal Acetate on Bleeding Patterns and Dysmenorrhea in Women With Adenomyosis
- Study of the Safety and Efficacy of Ulipristal Acetate (UPA) Used Daily as a Contraceptive
- A proof-of Concept, Randomized 3-month Study to Evaluate the Effects of Three Contraceptive Intrauterine Systems Delivering Copper and a Daily Dose of 5, 20 or 40 μg of Ulipristal Acetate (UPA)
- A Study of Use of Ella®, an Emergency Contraceptive, Under Simulated OTC Conditions
- Ulipristal Versus Placebo for Women With Bleeding Induced by Mirena
- A Study to Compare the Pharmacokinetics and Safety/Tolerability of BR-UPS (Ulipristal Acetate) 5 mg Tablet With Inisia (Ulipristal Acetate) 5 mg Tablet
- Intervention to End Recurrent Unscheduled Bleeding Trial
- Quality of Life Outcomes for Ulipristal Acetate and Tranexamic Acid in the Management of Heavy Menstrual Bleeding
- Compare Daily Ulipristal Acetate and Combined Oral Contraceptive Effects on Breast Epithelial Cell Proliferation
- Effectiveness of Orally Dosed Emergency Contraception in Obese Women - LNG
- Effectiveness of Orally Dosed Emergency Contraception in Obese Women - UPA
- Ulipristal Use in Chinese Population
- EC PK in Women With Normal and Obese BMI
- Study of Ulipristal Acetate in Female Patients With Moderately or Severely Impaired Renal Function, Compared With Matched Healthy Female Subjects
- IVF Outcome Following Treatment With Ulipristal Acetate for Myomatous Uterus After at Least One IVF Failure
- Ulipristal Acetate In Disease Charcot-Marie-Tooth Type of 1A
- Adenomyosis and Ulipristal Acetate
- Impact of Combined Hormonal Contraceptives on UPA
- Ulipristal Emergency Contraception Used Before or After Ovulation
- A Study to Evaluate the Effect of a Contraceptive Vaginal Ring Delivering Ulipristal Acetate Combined With a Single or Repeated Levonorgestrel on Inhibition of Ovulation, Endometrial Changes and Bleeding Patterns in Normal Cycling Women
- Endometrial Preparation Before Operative Hysteroscopy in Premenopausal Women
- Ulipristal Acetate 10 mg and Asisted Reproduction
- Breast Cancer - Anti-Progestin Prevention Study 1
- Ulipristal Acetate for the Preoperative Management of Hypoechoic Cellular Leiomyomas
- The Effect of Ulipristal Acetate (UPA) on Women Ovarian Reserve
- Ulipristal Acetate Versus GnRH Analogue Treatment Before Hysteroscopic Resection of Uterine Leiomyoma
- Ulipristal Acetate Versus GnRH Analogue and Myometrial Preservation
- Ulipristal for Endometriosis-related Pelvic Pain
- A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas
- A Study of the Efficacy and Safety of Ulipristal Acetate Intermittent Treatment for Abnormal Uterine Bleeding Associated With Leiomyomas
- Efficacy Study of Two Continuous Regimens of Oral Daily 5 mg or 10 mg of Ulipristal Acetate (UPA), Versus a Dose of 5.0mg UPA for 24/4 Days
- PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata
- PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata
- Assessment of Effects on Ovarian Activity of a Combined Oral Contraceptive Pill When Preceded by the Intake of ellaOne® or Placebo.
- Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma
- Levonorgestrel Intrauterine System For Emergency Contraception
- CDB-2914 for Abnormal Uterine Bleeding in Premenopausal Women
- Ulipristal Acetate on Progesterone Levels and Glycodelin-A Endometrial Pattern
- PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata (PEARLIII-extension Study)
- PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata
- Safety, Tolerability, and Efficacy of ellaOne® (Ulipristal Acetate) for Emergency Contraception in Postmenarcheal Adolescent Girls and Women
- PGL4001 Versus Placebo in Uterine Myomas
- PGL4001 Versus GnRH-agonist in Uterine Myomas
- Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914
Clinical trials list
click for details